Ample makes pact for percutaneous valve tool
This article was originally published in Clinica
Promising to accelerate the development of its percutaneous PS3 System for treating mitral valve regurgitation (MR) associated with congestive heart failure, Ample Medical has signed an investment and joint development deal with AGA Medical and Aberdare Ventures regarding the product.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.